Based on the Cronos Group Inc stock forecast from 3 analysts, the average analyst target price for Cronos Group Inc is CAD 2.81 over the next 12 months. Cronos Group Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Cronos Group Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Cronos Group Inc’s stock price was CAD 3.03. Cronos Group Inc’s stock price has changed by +5.21% over the past week, -0.33% over the past month and +10.18% over the last year.
No recent analyst target price found for Cronos Group Inc
No recent average analyst rating found for Cronos Group Inc
Company Overview Cronos Group Inc
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. Address: 111 Peter Street, Toronto, ON, Canada, M5V 2H1 Read Less
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, a...Read More
Frequently Asked Questions About Cronos Group Inc (CRON:CA) Stock
Based on ratings from 3 analysts Cronos Group Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, 1 sell and 2 hold ratings.
Unfortunately we do not have enough data on CRON:CA's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for CRON:CA is CAD 2.81 over the next 12 months. The maximum analyst target price is CAD 3.54 while the minimum anlayst target price is CAD 2.
CRON:CA stock's Price/Earning ratio is 46.76.
Our analysis grades CRON:CA stock's Price / Earning ratio at F. This means that CRON:CA stock's Price/Earning ratio is above 53% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSX exchange.
Based on this CRON:CA may be a overvalued for its sector.
The last closing price of CRON:CA's stock was CAD 3.03.
The most recent market capitalization for CRON:CA is CAD 1.16B.
Based on targets from 3 analysts, the average taret price for CRON:CA is projected at CAD 2.81 over the next 12 months.
This means that CRON:CA's stock price may go down by -7.33% over the next 12 months.
We can't find any ETFs which contains Cronos Group Inc's stock.
As per our most recent records Cronos Group Inc has 356 Employees.
Cronos Group Inc's registered address is 111 Peter Street, Toronto, ON, Canada, M5V 2H1.
You can get more information about it from Cronos Group Inc's website at https://www.thecronosgroup.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Cronos Group Inc (CRON:CA) Stock
Based on ratings from 3 analysts Cronos Group Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, 1 sell and 2 hold ratings.
Unfortunately we do not have enough data on CRON:CA's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for CRON:CA is CAD 2.81 over the next 12 months. The maximum analyst target price is CAD 3.54 while the minimum anlayst target price is CAD 2.
CRON:CA stock's Price/Earning ratio is 46.76.
Our analysis grades CRON:CA stock's Price / Earning ratio at F. This means that CRON:CA stock's Price/Earning ratio is above 53% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSX exchange.
Based on this CRON:CA may be a overvalued for its sector.
The last closing price of CRON:CA's stock was CAD 3.03.
The most recent market capitalization for CRON:CA is CAD 1.16B.
Based on targets from 3 analysts, the average taret price for CRON:CA is projected at CAD 2.81 over the next 12 months.
This means that CRON:CA's stock price may go down by -7.33% over the next 12 months.
We can't find any ETFs which contains Cronos Group Inc's stock.
As per our most recent records Cronos Group Inc has 356 Employees.
Cronos Group Inc's registered address is 111 Peter Street, Toronto, ON, Canada, M5V 2H1.
You can get more information about it from Cronos Group Inc's website at https://www.thecronosgroup.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CRON:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
